Correlation Between Ultramid-cap Profund and Biotechnology Ultrasector

Can any of the company-specific risk be diversified away by investing in both Ultramid-cap Profund and Biotechnology Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ultramid-cap Profund and Biotechnology Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ultramid Cap Profund Ultramid Cap and Biotechnology Ultrasector Profund, you can compare the effects of market volatilities on Ultramid-cap Profund and Biotechnology Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ultramid-cap Profund with a short position of Biotechnology Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ultramid-cap Profund and Biotechnology Ultrasector.

Diversification Opportunities for Ultramid-cap Profund and Biotechnology Ultrasector

0.4

Correlation Coefficient

Ultramid-cap Profund  Biotechnology Ultrasector

Very weak diversification

The 3 months correlation between Ultramid-cap and Biotechnology is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Ultramid Cap Profund Ultramid and Biotechnology Ultrasector Prof in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Ultrasector and Ultramid-cap Profund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ultramid Cap Profund Ultramid Cap are associated (or correlated) with Biotechnology Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Ultrasector has no effect on the direction of Ultramid-cap Profund i.e., Ultramid-cap Profund and Biotechnology Ultrasector go up and down completely randomly.

Pair Corralation between Ultramid-cap Profund and Biotechnology Ultrasector

Assuming the 90 days horizon Ultramid Cap Profund Ultramid Cap is expected to generate 0.7 times more return on investment than Biotechnology Ultrasector. However, Ultramid Cap Profund Ultramid Cap is 1.42 times less risky than Biotechnology Ultrasector. It trades about 0.05 of its potential returns per unit of risk. Biotechnology Ultrasector Profund is currently generating about -0.03 per unit of risk. If you would invest  4,288  in Ultramid Cap Profund Ultramid Cap on October 5, 2024 and sell it today you would earn a total of  839.00  from holding Ultramid Cap Profund Ultramid Cap or generate 19.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Ultramid Cap Profund Ultramid   vs.  Biotechnology Ultrasector Prof

Ultramid Cap Profund

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ultramid Cap Profund Ultramid Cap has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Ultramid-cap Profund is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biotechnology Ultrasector

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's forward indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Pair Trading with Ultramid-cap Profund and Biotechnology Ultrasector

The main advantage of trading using opposite Ultramid-cap Profund and Biotechnology Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ultramid-cap Profund position performs unexpectedly, Biotechnology Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Ultrasector will offset losses from the drop in Biotechnology Ultrasector's long position.

The idea behind Ultramid Cap Profund Ultramid Cap and Biotechnology Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.